Sanofi (SNYNF)
OTCMKTS
· Delayed Price · Currency is USD
108.11
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
$553,216
Profits / Employee
$69,455
Market Cap
136.42B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| CytoDyn | 9 |
| Northwest Biotherapeutics | 25 |
| SANUWAVE Health | 31 |
| Silence Therapeutics | 109 |
Sanofi News
- 23 hours ago - Notable healthcare headlines for the week: UnitedHealth, Moderna, Sanofi in focus - Seeking Alpha
- 2 days ago - Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn's disease - GlobeNewsWire
- 3 days ago - Stocks to watch today on 21 Feb: Cipla, Senores, Narayana Hrudayalaya, Sanofi in pharmaceuticals and healthcare sector - Business Upturn
- 3 days ago - Chronic Spontaneous Urticaria Market to Register Incremental Growth During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight - Benzinga
- 5 days ago - Sanofi: OpenAI's Research Agents Could Lead To Explosive Growth - Seeking Alpha
- 5 days ago - Sanofi to sell 50% stake in consumer health unit to CD&R - Seeking Alpha
- 5 days ago - Press Release: Sanofi and CD&R sign Opella share purchase agreement - GlobeNewsWire
- 5 days ago - Regeneron, Sanofi asthma therapy Dupixent under FDA review for rare skin condition - Seeking Alpha